Your browser doesn't support javascript.
loading
Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst, Annelienke M; Grootenhuis, Martha A; van den Akker, Erica L T; van den Heuvel-Eibrink, Marry M.
Affiliation
  • van Hulst AM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands. Electronic address: a.vanhulst@prinsesmaximacentrum.nl.
  • Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
  • van den Akker ELT; Erasmus MC, Sophia Children's Hospital, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
  • van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA Utrecht, the Netherlands.
Eur J Cancer ; 191: 112980, 2023 09.
Article in En | MEDLINE | ID: mdl-37574396

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials Limits: Child / Humans Language: En Journal: Eur J Cancer Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials Limits: Child / Humans Language: En Journal: Eur J Cancer Year: 2023 Type: Article